new Corona virus disease 2019. new Corona virus disease 2019
Conditions
Interventions
Intervention 1: Intervention group: COVID-19 standard treatment based on the protocol recommended by the Ministry of Health for hospitalized patients (Remdesivir, prophylactic anticoagulant, and low d
Sponsors
Artesh University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients who have positive PCR for COVID-19 Patients with COVID-19 who have been admitted to hospital
Exclusion criteria
Exclusion criteria: Patients who are pregnant or breastfeeding Patients with underlying diseases such as: diabetes, hypertension and cancer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ICU admission or intubation. Timepoint: During hospitalization, daily. Method of measurement: Evaluator report. | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical symptoms (cough intensity, The degree of shortness of breath). Timepoint: During hospitalization, daily. Method of measurement: Symptoms by asking the patient as a scale indicator and signs by monitoring the patient by the assessor.;Inflammatory markers (ESR, CRP, LDH, WBC). Timepoint: before and after the 5 days intervention. Method of measurement: Quantitative laboratory measurements of blood samples.;Clinical examinations (RR, SO2). Timepoint: During hospitalization, daily. Method of measurement: Through clinical examination and use of pulse oximeter. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNafiseh Hosseini Yekta
Artesh University of Medical Sciences
Outcome results
None listed